InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
Discover the complete record of transactions filed by Kelly John F.. Director active across 1 company, notably Prestige Consumer Healthcare Inc.. Aggregated, 1 disclosures have been published. History available since 5 August 2024. The latest transaction was filed on 5 August 2024 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
1 of 1 declaration